Apexium Financial’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$842K Buy
6,286
+15
+0.2% +$1.97K 0.04% 146
2025
Q2
$853K Buy
6,271
+37
+0.6% +$4.88K 0.05% 138
2025
Q1
$827K Buy
6,234
+2,830
+83% +$360K 0.05% 134
2024
Q4
$385K Buy
3,404
+793
+30% +$91.6K 0.02% 188
2024
Q3
$298K Buy
+2,611
New +$286K 0.02% 188
2024
Q2
Sell
-1,918
Closed -$218K 228
2024
Q1
$218K Sell
1,918
-961
-33% -$110K 0.02% 213
2023
Q4
$317K Buy
2,879
+803
+39% +$80.2K 0.02% 212
2023
Q3
$201K Buy
2,076
+11
+0.5% +$1.16K 0.02% 204
2023
Q2
$225K Sell
2,065
-2
-0.1% -$213 0.02% 199
2023
Q1
$209K Hold
2,067
0.02% 196
2022
Q4
$227K Sell
2,067
-682
-25% -$70.6K 0.02% 191
2022
Q3
$266K Buy
+2,749
New +$293K 0.03% 166

Other funds holding ABT

Apexium Financial's ABT Position: Q3 2025 in Review

Apexium Financial increased its Abbott (ABT) stake by 0.24% in Q3 2025, buying an estimated $1.97K and bringing the position to 6,286 shares worth $842K. The position accounts for 0.04% of the portfolio, ranked #146.

Apexium Financial first reported a position in ABT in Q3 2022 and has held it in 12 quarters since. The position peaked at $853K in Q2 2025. 3,172 funds tracked by Wall St. Rank hold ABT as of Q3 2025.

  • Apexium Financial held 6,286 shares of Abbott worth $842K as of Q3 2025.
  • Apexium Financial bought 15 Abbott shares in Q3 2025, an estimated $1.97K.
  • Abbott made up 0.04% of Apexium Financial's portfolio in Q3 2025, its #146 holding.
  • Apexium Financial first reported a position in Abbott in Q3 2022 and has held it in 12 quarters since.
  • Apexium Financial's Abbott position peaked at $853K in Q2 2025.
  • 3,172 funds tracked by Wall St. Rank held Abbott as of Q3 2025.

Based on Apexium Financial's 13F filing for Q3 2025, filed 18 Nov 2025.